261-270 of 292 results
Protecting innovation without patents - data exclusivity and market exclusivity
Developments in patent law and the consequential limitations on patentability for biologic medicines mean that data exclusivity and market exclusivity can be the primary protection afforded to originator biologic medicines This is most stark in the US where patent protection for biologic medicines ...
To bee, or not to bee… Generalised health claims under the Food Standards Code?
The New Zealand Court of Appeal considered an application by a honey producer seeking a declaration that the labelling of its honey products complied with the requirements for nutrition, health and related claims under the Food Standards Code. ...
The CoOL change is here
We provide an update on the new Country of Origin Labelling regime which came into effect on 1 July 2016 and the Federal Government’s proposed changes to the safe harbour provisions under the Australian Consumer Law. ...
Food imports and the Biosecurity Act: What’s changed
We report on recent changes to the law relating to the importation of food into Australia, introduced by the commencement of the Biosecurity Act 2015 (Cth). ...
The new FDA nutrition information panel guidelines
WE report on the new FDA guidelines regarding nutrition information labels for packaged foods sold in the USA. ...
Full Court comes down hard on business method patent, but software remains patentable
In an eagerly awaited appeal decision in emRPL Central v The Commissioner of Patentsem the Full Federal Court has decided that the evidence-gathering method the subject of RPL Centrals innovation patent was a mere scheme abstract idea or business method that did not constitute patentable subject ...
Patent examination guidelines in the wake of Myriad
Following public consultation on proposed examination guidelines issued on 16 October 2015 the Commissioner of Patents has established a revised examination practice taking into account the High Courts decision in emDArcy v Myriad Genetics Incem Dr Trevor Davies Partner at Allens Patent amp Trade ...
Food Law Bulletin
In this edition we look at the Federal Governments proposed Country of Origin Labelling that may be rolled out next year the impact on food producers of the broader reach for the health claims standard how ACCC proceedings and a new enforcement guide will give producers and consumers a clearer ...
Not quite business as usual - IP Australia takes pragmatic view of Myriad
IP Australia has taken a pragmatic approach to the Myriad decision that will give comfort to Australias biotechnology industry and research organisations that they can continue to carry out biological RD and be able to obtain patent protection for innovation in Australia Partner Dr Trevor Davies ...
High Court unanimously finds isolated genetic material not patentable
In the culmination of a hard-fought patent dispute the High Court of Australia has unanimously ruled that Myriad Genetics patent claims to isolated nucleic acid coding for the mutant or polymorphic BRCA1 polypeptide are not valid ...